Serial testing with the interferon-γ release assay in Portuguese healthcare workers
Open Access
- 19 August 2010
- journal article
- research article
- Published by Springer Nature in International Archives of Occupational and Environmental Health
- Vol. 84 (4) , 461-469
Abstract
Objectives Evidence for the utility of the new Mycobacterium tuberculosis (MTB) specific IFN-γ release assays in diagnosing latent tuberculosis infection (LTBI) is growing. However, data concerning conversion and reversion rates in serial testing of healthcare workers (HCWs) with an interferon-γ release assay are sparse. Methods Between February 2007 and September 2009, 670 HCWs in the University Hospital of Porto, Portugal were tested at least twice with QuantiFERON-TB® Gold In-Tube (QFT) for LTBI. The tuberculin skin test (TST) was performed simultaneously. QFT was considered positive if INF-γ ≥0.35 IU/mL. TST conversion was defined as an increase ≥10 or ≥6 mm compared to a baseline TST <10 mm. Results The second QFT was positive in 4.8% of the 376 HCWs with an INF-γ concentration at baseline below 0.1 IU/mL but in 48.8% of the 41 HCWs with an INF-γ concentration of 0.2 to <0.35 IU/mL. Out of 74 HCWs with a baseline INF-γ concentration ≥3.0 IU/mL, 4 (5.4%) reversed while 27 out of 55 HCWs (49%) with a baseline INF-γ concentration ≥0.35 to <0.7 IU/mL reversed to a negative QFT. Those 61 HCWs with TST conversion (increase ≥10 mm) were most often (78.7%) negative in both consecutive QFTs. Conclusion Our data suggests the use of an uncertainty zone between 0.2 and 0.7 IU/mL in serial testing with QFT. As long as the knowledge regarding disease progression in QFT-positive persons is limited, persons pertaining to this zone should be retested before being offered preventive chemotherapy.Keywords
This publication has 24 references indexed in Scilit:
- Follow-Up Study of Tuberculosis-Exposed Supermarket Customers with Negative Tuberculin Skin Test Results in Association with Positive Gamma Interferon Release Assay ResultsClinical and Vaccine Immunology, 2007
- T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forwardThe Lancet Infectious Diseases, 2007
- Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for ResearchAnnals of Internal Medicine, 2007
- Using ELISPOT to Expose False Positive Skin Test Conversion in Tuberculosis ContactsPLOS ONE, 2007
- Dynamic Antigen-specific T-Cell Responses after Point-Source Exposure to Mycobacterium tuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Serial Testing of Health Care Workers for Tuberculosis Using Interferon-γ AssayAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Avoiding the effect of BCG vaccination in detectingMycobacterium tuberculosisinfection with a blood testEuropean Respiratory Journal, 2006
- Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005.2005
- Targeted Tuberculin Testing and Treatment of Latent Tuberculosis InfectionAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Interpretation of Repeated Tuberculin Tests: Boosting, Conversion, and ReversionAmerican Journal of Respiratory and Critical Care Medicine, 1999